,
your personalized virtual assistant to find clinical trials. Go head, 
Craig Hofmeister, MD
The Ohio State University - ...Columbus, Ohio - 43210 (614-293-3507) Arthur G. James Cancer Hospital ...Columbus, Ohio - 43210-1240 (866-627-7616) Ohio state UniversityColumbus, Ohio - 43210 Ohio StateColumbus, Ohio - 43210 |
- CLINICAL TRIALS 6
- CONDITIONS8
- INTERVENTIONS15
- SINCE2007
MTD Safety and Efficacy of CC-4047 Alone With Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
May 2008 - September 2011
Vaccine Therapy in Treating Patients Who Have Undergone Autologous Stem Cell Transplant for High-Risk Lymphoma or Multiple Myeloma
December 2007 - November 2010
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
February 2010 - December 2014
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
May 2010 - May 2020
Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
March 2007 - June 2009
Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Persistent Multiple Myeloma
September 2008 - August 2010
Lymphoma
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Duodenal Neoplasms
Ileal Neoplasms
Jejunal Neoplasms
Intestinal Neoplasms
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Quality-Of-Life Assessment
Immunoenzyme Technique
Lenalidomide
Vorinostat
Bortezomib
Dexamethasone
Fluorescence Activated Cell Sorting
Immunologic Technique
Cc-4047
Npi-0052
Pneumococcal Polyvalent Vaccine
Aurora A Kinase Inhibitor Mln8237
Lenalidomide, Bortezomib And Dexamethasone
